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INTRODUCTION:  Zollinger–Ellison  syndrome  (ZES)  is caused  by  uninhibited  secretion  of gastrin  from  a
gastrinoma.  Gastrinomas  most  commonly  arise  within  the  wall  of  the  duodenum  followed  by  the  pan-
creas.  Primary  lymph  node  gastrinomas  have  also  been  reported  in  the  literature.  This  is a  case  of  ZES
where  preoperative  localization  revealed  a gastrinoma  in  a solitary  portacaval  lymph  node,  presumed  to
be  a primary  lymph  node  gastrinoma.
PRESENTATION  OF  CASE:  The  patient  is  a 57 year  old  female  diagnosed  with  ZES,  suspected  of  having  a
primary lymph  node  gastrinoma.  The  patient  underwent  an  exploratory  laparotomy  and  excision  of  a
portacaval  lymph  node  with  a frozen  section  which  was  positive  for gastrinoma.  Intraoperative  sonog-
raphy  of  the  pancreas,  upper endoscopy  with  transillumination  of the duodenum,  and  a duodenotomy
with  bimanual  examination  of  the  duodenal  wall  were  also  performed.  The  patient  was found  to  have  a
4  mm  duodenal  mass  near  the  pylorus,  which  was excised.
DISCUSSION:  Pathology  showed  that the  duodenal  mass was  primary  gastrinoma.  Serum  gastrin  levels
taken four  months  postoperatively  were  normal  and  the  repeat  octreotide  scan  did  not show any  evidence
of recurrence.
CONCLUSION:  Primary  lymph  node  gastrinoma  is a diagnosis  of  exclusion.  The duodenum  and  pancreas
must  be  fully  explored  to  rule out a primary  gastrinoma  that  may  be occult.
©  2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Zollinger–Ellison syndrome (ZES) is characterized by severe
eptic ulcer disease and often diarrhea caused by uninhibited
ecretion of gastrin from a gastrinoma that stimulates excessive
roduction and release of gastric acid. Originally described as pan-
reatic neuroendocrine tumors, gastrinomas are now known to
ost commonly arise within the wall of the duodenum (40–60%),
ollowed by the pancreas (∼20%).1,2 We  report a case of ZES
here preoperative localization revealed a gastrinoma in a soli-
ary portacaval lymph node, presumed to be a primary lymph node
astrinoma. On exploratory laparotomy, however, duodenotomy
evealed a 4 mm primary duodenal gastrinoma near the pylorus,
xcision of which proved curative as determined by a regression
o a normal fasting serum gastrin level. The case illustrates the
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diagnostic workup and operative procedures used to diagnose,
localize, and treat gastrinoma with a subsequent review of the lit-
erature that explores landmark studies in the role of surgery in
treating gastrinoma, the controversy over the existence of primary
lymph node gastrinomas, and the importance of intraoperative
exploration in the treatment of ZES.
2. Presentation of a case
A 57 year old woman  presented three times to the emergency
department over three weeks with recurrent complaints of nausea,
vomiting and profuse watery diarrhea. The patient was  empiri-
cally treated for Clostridium difﬁcile (C. diff) colitis. All stool studies,
including ova and parasites and C. diff toxins, were negative. In addi-
tion, a colonoscopy was negative for colitis or pseudo membranes,
showing only pan-diverticulosis. After her symptoms appeared to
improve with a course of antibiotics, she was  discharged with out-
patient follow-up only to return the following day with worsening
diarrhea and multiple episodes of emesis. Her vitals continued to
be normal with an unremarkable physical exam.
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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eig. 1. Computed tomography (CT) scan of abdomen. (a) Portacaval node on CT sca
b)  Intraoperative image of the portocaval node which was  positive for gastrinoma 
Further workup with abdominal computed tomography (CT)
nd magnetic resonance imaging (MRI) showed severe thickening
nd edema of the second through fourth portions of the duodenum
ith focal outpouchings of air suggestive of duodenal ulcers caused
y a gastrinoma. The diagnosis was conﬁrmed with a secretin stim-
lation test revealing a basal gastrin level of 1675 pg/ml which rose
o 17,488 pg/ml after 10 min, exceeding the commonly accepted
iagnostic threshold of a rise >200 pg/ml.3
A preoperative localization attempt was made with esoph-
gogastroduodenoscopy (EGD), which revealed multiple ulcers
hroughout the duodenum, and endoscopic ultra sound (EUS),
hich revealed an enlarged portacaval node measuring 16 mm by
9 mm with no other suspicious ﬁndings. Preoperative octreotide
can demonstrated an area of focal abnormal octreotide uptake that
orresponded to an enhancing portacaval node seen on CT (Fig. 1a)
nd on contrast-enhanced MRI. No other areas of uptake were iden-
iﬁed. She was started on a high dose proton pump inhibitor (PPI)
ith improvement of symptoms.
After a second EUS showed resolution of the ulcers and inﬂam-
ation after a few weeks of PPI treatment, the patient underwent
perative exploration with curative intent. The right colon was
obilized and the duodenum Kocherized to reveal the pathologi-
al portacaval node (Fig. 1b) situated just posterior to the head of
he pancreas and portal triad, and anterior to the vena cava. The
ode was carefully excised using sharp dissection. An intraoper-
tive frozen section was sent to pathology and was  found to be
ositive for gastrinoma.
Intraoperative sonography was performed on both the pancreas
nd the area of the portacaval node with no abnormal lesions noted.
ig. 2. Excision of gastrinoma. (a) Manual palpation of duodenum after duodenotomy. (
nucleation, this was  primarily closed.bdomen, corresponding to area of abnormal octreotide uptake on octreotide scan.
zen and ﬁnal pathology.
Upper endoscopy with transillumination of the duodenum also
yielded no abnormalities. Finally, a 5 cm longitudinal duodenotomy
was created. Digital and bimanual examination of the entire wall of
the duodenum (Fig. 2a) from the pylorus to the third portion was
performed. A 4 mm ﬁrm nodule was  palpated at the anterior infe-
rior wall of the proximal duodenum just distal to the pylorus. The
nodule was excised full thickness from the outer duodenal wall
(Fig. 2b and c) and a frozen section submitted to pathology was
consistent with a gastrinoma. The duodenotomy was  closed trans-
versely in two  layers as was  the opening at the site of the excision
of the duodenal lesion.
The ﬁnal pathology conﬁrmed the duodenal nodule as the gastri-
noma primary. The patient’s post-operative course was uneventful
and she was discharged home one week later. Four months post-
operatively, her fasting gastrin level was 77 pg/ml and serotonin
level was  152 ng/ml, both within normal limits. Patient also under-
went a repeat octreotide scan which did not show any evidence of
recurrence.
3. Discussion
The treatment for ZES has evolved as our understanding of the
natural course of the disease has grown along with the develop-
ment of anti-acid medications. Historically, gastrectomy was  the
treatment of choice; however, current medical management with
proton pump inhibitors effectively controls gastric acid hypersecre-
tion with a resultant resolution of symptoms.4 Sixty to 90 percent
of gastrinomas are malignant with the potential to metastasize
to the liver, which accounts for the vast majority of morbidity
b) Duodenal nodule, found to be gastrinoma. (c) Defect in the duodenal wall after
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nd mortality associated with ZES and the rationale for surgi-
al intervention.1 Although the majority of gastrinomas are slow
rowing, roughly 25 percent exhibit rapid growth and present
ith concurrent liver metastasis, an indicator of an aggressive dis-
ase course with a signiﬁcantly worsened prognosis.5 In a series
f 160 patients who underwent surgical resection of gastrinomas
no hepatic metastasis) vs. 35 patients managed with conservative
edical approach, surgery was shown to achieve long-term cure
n 41 percent with a greatly reduced likelihood of liver metastasis
29% vs. 5%, p = 0.0002), and prolonged 15-year survival (98% vs.
4%, p = 0.0002).1 Based on this study and on smaller series that
ave reached similar conclusions, patients with sporadic gastrino-
as  who do not have evidence of liver metastases should be offered
xploratory laparotomy and resection with curative intent.6,7 In
ontrast, the role of surgery for patients with gastrinoma in the
ontext of MEN1 (20% of patients with ZES), hepatic metastases,
nd those with occult disease with no primary tumor identiﬁed
reoperatively remains complicated and controversial.8
The existence of primary lymph node gastrinomas is a much
ebated and controversial topic in the literature.9–12 There have
een many reports of patients with ZES who had only lymph nodes
esected and were cured as assessed by biochemical testing and
maging studies in both the short and long term.13–16 Of those gas-
rinomas not localized to the duodenum or pancreas, the most
ommon site of gastrinoma occurrence is within a lymph node
ound in the gastrinoma triangle, an area deﬁned as the conﬂu-
nce of the cystic and common bile duct superiorly, the second
nd third portions of the duodenum inferiorly, and the neck and
ody of the pancreas medially, both dorsally and ventrally.17 Nor-
on et al. showed in a series of 176 patients with ZES (138 sporadic,
8 MEN1) that 26 of 45 patients were disease free soon after lymph
ode only resection, 18 of which (10%) remained disease-free after
n average of 10.4 years follow up while 8 (5%) relapsed, resulting
n reoperation in 4 patients, of which 3 were found to have a duo-
enal primary gastrinoma.10 It has been theorized that pancreatic
tem cells from the ventral pancreatic bud become dispersed and
re incorporated into lymph tissue and the duodenal wall during
mbryonic development, which is supported by pathological stud-
es that report ﬁndings of neuroendocrine cells in the region almost
xclusively deﬁned by the gastrinoma triangle.17–19
However, even with the likely existence of a primary lymph
ode gastrinoma, this remains a diagnosis of exclusion. Norton et al.
emphasized that a missed duodenal primary tumor could easily
be mistaken for a primary lymph node gastrinoma.10 Even when
imaging is negative for sporadic ZES, routine surgical exploration
is warranted to minimize the chance of metastasis to the liver; an
experienced surgeon can ﬁnd a gastrinoma in nearly every patient
with negative imaging and achieve similar cure rates as com-
pared to patients with positive imaging.20 In addition, Zogakis et al.
showed in a series of 63 patients with a primary duodenal gastri-
noma that only 10 percent of the primary gastrinomas were found
preoperatively as their small size precludes detection.21 Intraoper-
ative techniques used to localize a gastrinoma include sonogram,
transillumination, and duodenotomy, which have been shown to
detect signiﬁcantly more gastrinomas (94% vs. 64%), resulting in a
higher cure rate.22 In another analysis of his cohort, Norton et al.
showed that use of duodenotomy speciﬁcally increased both the
short and long term cure rates.23
4. Conclusion
Once a diagnosis of sporadic gastrinoma has been made, a com-
plete intraoperative search for a primary, including duodenotomy
with total tumor excision should be the standard of care to max-
imize the chance for cure and minimizing further morbidity and
mortality associated with either a repeat operation or metastasis.
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Key learning points
• Even when imaging is negative for sporadic Zollinger–Ellison Syndrome, surgical exploration is warranted to minimize
the chance of metastasis to the liver.
• Duodenotomy is Warranted During Surgical Exploration for a Suspected Primary lymph node gastrinoma.
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